ZFIN ID: ZDB-PUB-180710-2
Nile tilapia fry fed on antimicrobial peptide Epinecidin-1-expressing Artemia cyst exhibit enhanced immunity against acute bacterial infection
Ting, C.H., Chen, Y.C., Chen, J.Y.
Date: 2018
Source: Fish & shellfish immunology   81: 37-48 (Journal)
Registered Authors: Chen, Jyh-Yih
Keywords: Antimicrobial peptide, Epinecidin-1, Immunity, Microinjection, Tol2-transposon
MeSH Terms:
  • Acute Disease
  • Animal Feed*
  • Animals
  • Animals, Genetically Modified
  • Antimicrobial Cationic Peptides/administration & dosage*
  • Aquaculture
  • Artemia*
  • Bacterial Infections/immunology
  • Bacterial Infections/veterinary*
  • Cichlids/immunology*
  • Fish Diseases/immunology*
  • Fish Diseases/microbiology
  • Fish Proteins/genetics
  • Fish Proteins/immunology
  • Immunity, Innate
  • Larva
  • Streptococcal Infections/immunology
  • Streptococcal Infections/veterinary
  • Streptococcus iniae
  • Vibrio Infections/immunology
  • Vibrio Infections/veterinary
  • Vibrio vulnificus
PubMed: 29981882 Full text @ Fish Shellfish Immunol.
Artemia are often used as a live feed for fry in aquaculture. We have previously demonstrated that supplementing adult zebrafish feed with Artemia, which express an Epinephelus coioides-derived antimicrobial peptide, Epinecidin-1 (Epi-1), protects against bacterial infection. Thus, Artemia may serve as a bioreactor for producing biofunctional molecules. However, the application of Epi-1 transgenic Artemia in larval aquaculture of commercial fish species has not been investigated. Here we used a Tol2-transposon system to generate stable Epi-1 expressing Artemia. Nile tilapia (Oreochromis niloticus) fry were then fed with decapsulated transgenic cysts and acutely challenged with Gram-positive Streptococcus iniae or Gram-negative Vibrio vulnificus (204). Survival analysis revealed that tilapia fry fed with Epi-1 transgenic cysts were resistant to acute bacterial infection. Immune-related gene expression profiling showed that S. iniae and V. vulnificus inoculations produced distinct immunomodulatory effects in the tilapia fry. Upon S. iniae infection, tilapia fry fed on control diet exhibited an immune response dominated by Tlr-7/MyD88, wherein Tnf-α, Il-8 and Cxcl-10 expression were all induced; conversely, the tilapia fry fed with Epi-1 transgenic cysts showed a Tlr-2/Tlr-5-dominant immune response, marked by the induction of Il-1β, Il-8 and Il-12 expression. However, after V. vulnificus (204) infection control fry exhibited a Tlr-2/MyD88/Traf-6-dominant response with activation of Tnf-α and Il-8 expression; meanwhile tilapia fry fed on Epi-1 transgenic cyst showed a dominant Tlr-2/Tlr-5-mediated immune response, including induction of Il-1β, Il-8, Il-12, and Cxcl-10 expression. These findings suggest that feeding larval fish fry with Epi-1 transgenic Artemia cysts confers enhanced immunity toward bacterial challenge. Epi-1 transgenic cysts should therefore be considered as a potential functional feed for larval aquaculture.